ITV

Tag: Alkem Laboratories

  • Alkem Laboratories launches “Healthy Lungs Initiative” on World Rare Disease Day

    Alkem Laboratories launches “Healthy Lungs Initiative” on World Rare Disease Day

    Mumbai: As the world prepares to observe World Rare Disease Day on 29 February 2024, the focus is on the critical need to tackle rare lung diseases affecting individuals globally. This day serves as a poignant reminder of the challenges faced by those living with rare conditions and emphasizes the urgency of raising awareness, promoting research, and improving access to care for individuals battling rare lung diseases.

    Alkem Laboratories, through its “Healthy Lungs Initiative” has been at the forefront of addressing these challenges. This comprehensive program focuses on raising awareness, promoting preventive measures, and facilitating access to diagnosis and treatment for various respiratory conditions, including rare lung diseases.

    In support of World Rare Disease Day, Alkem Laboratories is organizing patient education programs across India. These programs aim to provide valuable information and resources to individuals and families affected by rare lung diseases, empowering them to better understand and manage their conditions. Additionally, Alkem Laboratories is conducting awareness campaigns on social media through its initiative, Healthy Lungs, reaching a broader audience and fostering community engagement in the fight against rare lung diseases.

    Alkem Laboratories confirms its commitment to improving lung health and assisting those impacted by rare lung diseases. Through ongoing efforts such as the Healthy Lungs initiative, the firm remains committed to making a significant difference in the lives of those suffering from uncommon lung diseases.

    Rare diseases present a significant health challenge globally, affecting an estimated 3.5–5.9 per cent of the world’s population, which corresponds to 263 to 446 million people worldwide. However, an estimated 72 to 96 million people in India suffer from rare diseases. The Indian Council of Medical Research (ICMR) maintains the National Registry for Rare Diseases, which collects epidemiological data on rare diseases. Until 31 October 2021, 4,001 rare disease cases had been identified.

    India faces a significant burden of rare lung diseases; the national burden of Interstitial Lung Diseases (ILDs) was estimated to be 0.45–0.89 million.4 Recent studies further highlight the prevalence of rare lung and obstructive airway diseases, adding to the growing concern.

  • Alkem Laboratories’ ‘Healthy Lungs’ campaign aims to clear the air

    Alkem Laboratories’ ‘Healthy Lungs’ campaign aims to clear the air

    Mumbai: With the onset of winter, India’s air quality takes a dangerous plunge, exposing its citizens to heightened levels of pollution and a surge in pulmonary stress. As the world grapples with environmental challenges, Alkem Laboratories spread awareness about the harrowing issue of winter pollution and its adverse effects impacting stress on lungs called pulmonary stress through its campaign ‘Healthy Lungs.’

    Winter in India not only brings chilly temperatures but also an alarming rise in air pollution. Recent studies reveal that 14 out of the 20 most polluted cities globally are located in India, with air pollution levels escalating during the winter season. This, in turn, contributes to rising cases of pulmonary stress causing exacerbations of Chronic Obstructive Pulmonary Disease (COPD) and asthma, during the colder months. Data from the World Health Organization underscores the urgency of this campaign, indicating that over a million people succumb to air pollution-related diseases in India annually.

    Alkem Laboratories Ltd president and head of acute business Sudipta Roy expressed the importance of their ongoing campaign, ‘Healthy Lungs,’ which can be accessed at www.thehealthylungs.com. Mr. Roy stated, “The statistics are staggering. Air pollution in India resulted in 1.67 million deaths in 2019, marking the largest pollution-related death toll in any country worldwide. The economic losses associated with this crisis amounted to a staggering $36.8 billion. We cannot afford to turn a blind eye to these alarming figures.”

    What sets India apart is the extent to which air pollution exceeds international guidelines. On average, India’s cities surpass the World Health Organization’s recommended limits for PM 2.5 in the atmosphere by a staggering 500 per cent. This dangerous phenomenon can be attributed to emissions from vehicular traffic, the burning of fossil fuels in households, particularly by economically disadvantaged families, and the fumes emanating from waste burning. The consequences are devastating, especially for those living in densely populated urban areas.

    ‘Healthy Lungs’ aims to raise awareness about the gravity of the situation and empower citizens with the knowledge and tools to protect their respiratory health during the challenging winter months. The initiative will focus on advocating for cleaner air and providing guidance on mitigating exposure to harmful pollutants. The initiative also conducts >600 camps and clinics across India to facilitate early diagnosis and treatment of respiratory ailments. These timely interventions have started making a significant difference in managing respiratory conditions like Asthma and COPD. Additionally, Alkem Laboratories will work towards promoting research and development in the field of respiratory medicine to provide innovative solutions and therapies for those affected by pulmonary stress.

    “By launching this campaign, Alkem Laboratories Limited is taking a proactive role in combating the dire consequences of winter pollution in India. The company believes that every individual has the right to breathe clean and healthy air, regardless of the season. Together, we can make a significant impact in reducing the pulmonary stress that plagues our nation during the winter months,” added Sudipta Roy.